AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks

Here's Why Investors Should Retain Alcon (ALC) Stock For Now

02:02pm, Thursday, 09'th Jun 2022 Zacks Investment Research
Investors are optimistic about Alcon's (ALC) better-than-expected results and robust performance across its popular franchises.
Investors are optimistic about Alcon's (ALC) better-than-expected results and robust performance across its popular franchises.

Alcon: Revisiting The Investment Thesis

01:13am, Friday, 03'rd Jun 2022
Alcon continues to grow at a double-digit rate and is on track to achieve management's full-year guidance. Both the Surgical and the Vision Care segments delivered double-digit growth, which highligh

Alcon (ALC) Signs EYSUVIS-Buyout Deal With Kala Pharmaceuticals

03:28pm, Monday, 23'rd May 2022 Zacks Investment Research
The acquisition of EYSUVIS complements Alcon's (ALC) Systane family of eye drops offering, strengthening its treatment options for dry eye disease.
The acquisition of EYSUVIS complements Alcon's (ALC) Systane family of eye drops offering, strengthening its treatment options for dry eye disease.

Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Grow

05:16pm, Thursday, 12'th May 2022 Zacks Investment Research
Alcon (ALC) delivers better-than-expected results in the first quarter, with strong performance across both franchises driving the top line.
Alcon (ALC) delivers better-than-expected results in the first quarter, with strong performance across both franchises driving the top line.

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2022

02:04pm, Thursday, 12'th May 2022 Benzinga
Upgrades For Warner Bros.Discovery Inc (NASDAQ:WBD), Cowen & Co. upgraded the previous rating of Market Perform to Outperform. The current stock performance of Warner Bros.Discovery shows a 52-week-h
Alcon Inc. (NYSE:ALC ) Q1 2022 Results Conference Call May 11, 2022 8:00 AM ET Company Participants Dan Cravens - VP, IR David Endicott - CEO Tim Stonesifer - CFO Conference Call Participants Daniel B

Alcon (ALC) to Report Q1 Earnings: What's in the Cards?

03:05pm, Monday, 09'th May 2022 Zacks Investment Research
Strength in Vision Care with the addition of new products and recent acquisition is likely to have contributed to Alcon's (ALC) first-quarter performance.
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how CGC, HAE and ALC are poised ahead of their earnings releases.

What's in the Offing for Synaptics (SYNA) This Earnings Season?

11:14am, Tuesday, 03'rd May 2022 Zacks Investment Research
Synaptics' (SYNA) third-quarter fiscal 2022 performance is likely to have benefited from increased bookings and new Organic Light Emitting Diode touch-sensor design wins.

EPAM Systems (EPAM) to Report Q1 Earnings: What's in Store?

04:21pm, Monday, 02'nd May 2022 Zacks Investment Research
Though the accelerated digital modernization across industries is likely to aid EPAM Systems' (EPAM) Q1 results, the discontinuation of Russian operations is likely to have hurt the top and bottom lin

Ball Corp (BLL) to Report Q1 Earnings: What's in the Offing?

03:50pm, Monday, 02'nd May 2022 Zacks Investment Research
Ball Corp's (BLL) Q1 performance is likely to reflect benefits from solid demand for beverage can packaging, can plant capacity expansions and robust aerospace backlog.

fuboTV (FUBO) to Report Q1 Earnings: What's in the Cards?

02:17pm, Monday, 02'nd May 2022 Zacks Investment Research
fuboTV's (FUBO) first-quarter results are expected to reflect growth in paid subscribers and viewing supported by increased advertiser demand on the company's sports-first live TV streaming platform.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE